The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Discovery of a Potent, Selective, and Orally Efficacious Pyrimidinooxazinyl Bicyclooctaneacetic Acid Diacylglycerol Acyltransferase-1 Inhibitor
Abstract
Inhibition of DGAT-1 is increasingly seen as an attractive mechanism with the potential for treatment of obesity and other elements of the metabolic syndrome. We report here a bicyclooctaneacetic acid derivative in the pyrimidinooxazine structural class of DGAT-1 inhibitors that has good potency, selectivity, and pharmacokinetic characteristics across a variety of species. This compound is an effective inhibitor of DGAT-1 in both intestinal and adipose tissue, which results in a reduction in body weight or body weight gain following oral administration in both mouse and rat models of dietary-induced obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We identified a pocket (median pLDDT of 93.7) in which we were able to dock the inhibitor and observe specific interactions (Fig. 3b) that were not recapitulated in a negative example49 (Extended Data Fig. 5 and Supplementary Methods 2).”
From Highly accurate protein structure prediction for the human proteome (2021) · cites this paper as [49]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cases, S., Smith, S. J., Zheng, Y.-W., Myers, H. M., Lear, S. R., Sande, E., Novak, S., Collins, C., Welch, C. B., Lusis, A. J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13018 · Cited by 1,123
DGAT2 Is a New Diacylglycerol Acyltransferase Gene Family
Lardizabal, K. D., Mai, J. T., Wagner, N. W., Wyrick, A., Voelker, T., & Hawkins, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106168200 · Cited by 371
Chen, H. C., & Farese, R. V. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000151874.81059.ad · Cited by 171
Zhao, G., Souers, A. J., Voorbach, M. J., Falls, H. D., Droz, B. A., Brodjian, S. J., Lau, Y. Y., Iyengar, R. R., Gao, J., Judd, A. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7013887 · Cited by 139
Silversand, C., & Haux, C. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00385-x · Cited by 132
Bray, G. A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0680124 · Cited by 128
Acyl Glucuronides: Biological Activity, Chemical Reactivity, and Chemical Synthesis
Stachulski, A. V., Harding, J., Lindon, J. C., Maggs, J. L., Park, B. K., & Wilson, I. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060599z · Cited by 123
Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
Ebner, T., Heinzel, G., Prox, A., Beschke, K., & Wachsmuth, H. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15038-6 · Cited by 98
[11] Diacylglycerol acyltransferase and monoacylglycerol acyltransferase from liver and intestine
Coleman, R. (1992) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(92)09013-s · Cited by 83
Research works printed but not linked: 2
- Nuding G., 1996, Synthesis, 71, 6
- Stepanov F. N., 1970, Z. Org. Khim., 6, 1623
Cited by
Highly accurate protein structure prediction for the human proteome
Tunyasuvunakool, K., Adler, J., Wu, Z., Green, T., Zielinski, M., Žídek, A., Bridgland, A., Cowie, A., Meyer, C., Laydon, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03828-1 · Cited by 3,025
Locke, G. M., Bernhard, S. S. R., & Senge, M. O. (2019) · Chemistry – A European Journal · doi:10.1002/chem.201804225 · Cited by 261
Cao, J., Zhou, Y., Peng, H., Huang, X., Stahler, S. L., Suri, V., Qadri, A., Gareski, T., Jones, J. E., Hahm, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.245456 · Cited by 170
How lipid droplets “TAG” along: Glycerolipid synthetic enzymes and lipid storage
Wang, H., Airola, M. V., & Reue, K. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.06.010 · Cited by 145
Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1
Dow, R. L., Li, J., Pence, M. P., Gibbs, E. M., LaPerle, J. L., Litchfield, J., Piotrowski, D. W., Munchhof, M. J., Manion, T. B., Zavadoski, W. J., et al. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200051p · Cited by 104
DeVita, R. J., & Pinto, S. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4007033 · Cited by 102
Liu, L., Yu, S., Khan, R. S., Ables, G. P., Bharadwaj, K. G., Hu, Y., Huggins, L. A., Eriksson, J. W., Buckett, L. K., Turnbull, A. V., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011395 · Cited by 97
Self-citationLee, B., Fast, A. M., Zhu, J., Cheng, J., & Buhman, K. K. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002311 · Cited by 87
Liu, L., Trent, C. M., Fang, X., Son, N.-H., Jiang, H., Blaner, W. S., Hu, Y., Yin, Y., Farese, R. V., Homma, S., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.601864 · Cited by 76
Self-citationAbles, G. P., Yang, K. J. Z., Vogel, S., Hernández‐Ono, A., Yu, S., Yuen, J. J., Birtles, S., Buckett, L. K., Turnbull, A. V., Goldberg, I. J., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m029041 · Cited by 78
Self-citationMultiplicity conversion based on intramolecular triplet-to-singlet energy transfer
Cravcenco, A., Hertzog, M., Ye, C., Iqbal, M. N., Müeller, U., Lars Eriksson, A., & Börjesson, K. (2019) · Science Advances · doi:10.1126/sciadv.aaw5978 · Cited by 66
The use of 2-(1-alkoxyalkylidene)-1,3-dicarbonyl compounds in organic synthesis
Kudyakova, Y. S., Бажин, Д. Н., Goryaeva, M. V., Burgart, Y. V., & Салоутин, В. И. (2014) · Russian Chemical Reviews · doi:10.1070/rc2014v083n02abeh004388 · Cited by 53
McCoull, W., Addie, M. S., Birch, A. M., Birtles, S., Buckett, L. K., Butlin, R. J., Bowker, S. S., Boyd, S., Chapman, S., Davies, R. D. M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.117 · Cited by 45
Self-citationNaik, R., Brice, O.-O., Kim, M., Choi, Y., Lee, H. S., & Lee, K. (2014) · ChemMedChem · doi:10.1002/cmdc.201402069 · Cited by 46
Qian, Y., Wertheimer, S. J., Ahmad, M., Cheung, A. W., Firooznia, F., Hamilton, M. M., Hayden, S., Li, S., Marcopulos, N., McDermott, L. A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101580m · Cited by 43
Shih, C., Ciou, J.-L., Lin, C., Wu, J., & Ho, H. (2013) · Molecules · doi:10.3390/molecules18032726 · Cited by 42
“Moreover, T2 and T3 caused a decrease in DGAT1 expression, attenuated body weight gain in diet-induced mice without affecting food intake which is consistent to reports of other DGAT1 inhibitors in the literature [38,39].”
ResultSchober, G., Arnold, M., Birtles, S., Buckett, L. K., Pacheco‐López, G., Turnbull, A. V., Langhans, W., & Mansouri, A. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035154 · Cited by 47
Self-citationBarlind, J. G., Bauer, U. A., Birch, A. M., Birtles, S., Buckett, L. K., Butlin, R. J., Davies, R. D. M., Eriksson, J. W., Hammond, C. D., Hovland, R., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301296t · Cited by 39
Self-citationMaciejewski, B. S., LaPerle, J. L., Chen, D., Ghosh, A., Zavadoski, W. J., McDonald, T. S., Manion, T. B., Mather, D., Patterson, T. A., Hanna, M., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00384.2012 · Cited by 42
“The blunting of TG and retinyl palmitate absorption with pharmacological inhibition of DGAT1 in humans is in agreement with previously reported rodent (1, 4, 19, 32, 60) and human (1) studies.”
BackgroundResultDevelopment of Novel Benzomorpholine Class of Diacylglycerol Acyltransferase I Inhibitors
Zhou, G., Zorn, N., Ting, P. C., Aslanian, R. G., Lin, M., Cook, J., Lachowicz, J. E., Lin, A., Smith, M., Hwa, J. J., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400527n · Cited by 36
McLaren, D. G., He, T., Wang, S.-P., Mendoza, V., Rosa, R. L., Gagen, K., Bhat, G., Herath, K. B., Miller, P. L., Stribling, S., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011049 · Cited by 37
Self-citationYeh, V. S. C., Beno, D. W. A., Brodjian, S. J., Brune, M. E., Cullen, S. C., Dayton, B. D., Dhaon, M. K., Falls, H. D., Gao, J., Grihalde, N. D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201524g · Cited by 34
Sustainable Practices in Medicinal Chemistry Part 2: Green by Design
Aliagas, I., Berger, R., Goldberg, K., Nishimura, R. T., Reilly, J., Richardson, P., Richter, D., Sherer, E. C., Sparling, B. A., & Bryan, M. C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01837 · Cited by 36
Natural products from plants targeting key enzymes for the future development of antidiabetic agents
Mata, R., Flores‐Bocanegra, L., Ovalle‐Magallanes, B., & Figueroa, M. (2023) · Natural Product Reports · doi:10.1039/d3np00007a · Cited by 37
Yamamoto, T., Yamaguchi, H., Miki, H., Shimada, M., Nakada, Y., Ogino, M., Asano, K., Aoki, K., Tamura, N., Masago, M., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.050 · Cited by 33
Chandak, P. G., Obrowsky, S., Radović, B., Doddapattar, P., Aflaki, E., Kratzer, A., Doshi, L. S., Povoden, S., Ahammer, H., Höefler, G., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.08.010 · Cited by 33
Liu, J., Gorski, J. N., Gold, S. J., Chen, D., Chen, S., Forrest, G., Itoh, Y., Marsh, D. J., McLaren, D. G., Shen, Z., et al. (2013) · Obesity · doi:10.1002/oby.20193 · Cited by 30
“Preclinical efficacy of small molecule DGAT1 inhibitors was demonstrated in rodent proof of concept studies for diminished postprandial hyperlipidemia and resistance to both DIO and liver steatosis (14-20).”
BackgroundInhibitors of diacylglycerol acyltransferase: a review of 2008 patents
King, A. J., Judd, A. S., & Souers, A. J. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903499305 · Cited by 29
“Potent, small molecule inhibitors of DGAT-1 have recently been reported to recapitulate the major phenotypic characteristics of the DGAT-1 knockout mice, most notably weight-loss and reductions in postprandial serum triglyceride concentrations in rodent models [14-16].”
BackgroundSerrano‐Wu, M. H., Coppola, G. M., Gong, Y., Neubert, A. D., Chatelain, R. E., Clairmont, K. B., Commerford, R., Cosker, T., Daniels, T., Hou, Y. M., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3000512 · Cited by 28
Nakada, Y., Aicher, T. D., Huérou, Y. L., Turner, T. M., Pratt, S. A., Gonzales, S. S., Boyd, S. A., Miki, H., Yamamoto, T., Yamaguchi, H., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.067 · Cited by 27
Tsuda, N., Kumadaki, S., Higashi, C., Ozawa, M., Shinozaki, M., Kato, Y., Hoshida, K., Kikuchi, S. S., Nakano, Y., Ogawa, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112027 · Cited by 27
“Compounds Compound A (4-[4-(4-amino-2,7,7-trimethyl-7H-pyrimido[4,5b][1,4]oxazin-6-yl)phenyl]-trans-Cyclohexaneacetic acid, Figure 1A), described in the patent application from the Japan Tobacco [8], has been reported as a potent DGAT1 inhibitor by AstraZeneca [9].”
BackgroundZhang, J., Xu, D. Q., Nie, J., Cao, J., Zhai, Y., Tong, D., & Shi, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.530022 · Cited by 26
Sachdev, V., Leopold, C., Bauer, R., Patankar, J. V., Iqbal, J., Obrowsky, S., Boverhof, R., Doktorova, M., Scheicher, B., Goeritzer, M., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.06.014 · Cited by 28
“Pharmacological DGAT1 inhibition studies in animal models have consistently demonstrated reduction in diet-induced weight gain and postprandial chylomicron secretion [10,11].”
Self-citationTejedor, D., Díaz‐Díaz, A., Diana‐Rivero, R., Delgado‐Hernández, S., & García‐Tellado, F. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b03558 · Cited by 24
Lee, K., Goo, J.-I., Jung, H. Y., Kim, M., Boovanahalli, S. K., Park, H. R., Kim, M.-O., Kim, D., Lee, H. S., & Choi, Y. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.10.046 · Cited by 26
The influence of physicochemical properties on the reactivity and stability of acyl glucuronides
Camilleri, P., Buch, A., Soldo, B., & Hutt, A. J. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1384967 · Cited by 22
“(30) Cl N CH3H3C HO S HO HO HO HO O O O O (30a) Cl N CH3H3C HO HO HO HO S O− O O O O The acyl glucuronide (31) (t½, 64 h) (Birch et al., 2009) formed as a metabolite of the corresponding experimental drug, is more stable than montelukast acyl glucuronide (30).”
BackgroundNovel therapeutics and targets for the treatment of diabetes
Aicher, T. D., Boyd, S. A., McVean, M., & Celeste, A. J. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.1 · Cited by 22
Yamamoto, T., Yamaguchi, H., Miki, H., Kitamura, S., Nakada, Y., Aicher, T. D., Pratt, S. A., & Kato, K. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.040 · Cited by 19
Effects of aerobic exercise on the body composition and lipid profile of overweight adolescents
Silva, D. A. S., Petróski, E. L., & Pelegrini, A. (2014) · Revista Brasileira de Ciências do Esporte · doi:10.1590/s0101-32892014000200002 · Cited by 19
The role of substituents in retro Diels–Alder extrusion of CO2 from 2(H)-pyrone cycloadducts
Abdullahi, M. H., Thompson, L. M., Bearpark, M. J., Vinader, V. M., & Afarinkia, K. (2016) · Tetrahedron · doi:10.1016/j.tet.2016.07.066 · Cited by 19
Hong, D. J., Jung, S. H., Kim, J., Jung, D., Ahn, Y., Suh, K. H., & Min, K. H. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1693555 · Cited by 21
Urner, L. M., Sekita, M., Trapp, N., Schweizer, W. B., Wörle, M. D., Gisselbrecht, J., Boudon, C., Guldi, D. M., & Diederich, F. (2014) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201403252 · Cited by 16
Diacylglycerol Acyltransferase-1 (DGAT1) Inhibition Perturbs Postprandial Gut Hormone Release
Lin, H. V., Chen, D., Shen, Z., Zhu, L., Ouyang, X., Vongs, A., Kan, Y., Levorse, J. M., Kowalik, E. J., Szeto, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054480 · Cited by 16
“Several small molecule DGAT1 inhibitors have been reported to ameliorate obesity in rodents [11–15].”
Nakada, Y., Ogino, M., Asano, K., Aoki, K., Miki, H., Yamamoto, T., Kato, K., Masago, M., Tamura, N., & Shimada, M. (2010) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.58.673 · Cited by 16
Patent landscape for discovery of promising acyltransferase DGAT and MGAT inhibitors
Zambre, V. P., Khamkar, S. M., Gavhane, D. D., Khedkar, S. C., Chavan, M. R., Pandey, M. M., Sanap, S. B., Patil, R. B., & Sawant, S. D. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1815707 · Cited by 16
Kandre, S., Bhagat, P. R., Reddy, M. M. K., Dalal, R., Dixit, A. V., Deshmukh, N., Anthony, J., Bose, J. S., Raghuram, A., Sharma, R. K., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.077 · Cited by 15
ACAT-selective and Nonselective DGAT1 Inhibition
Floettmann, J. E., Buckett, L. K., Turnbull, A. V., Smith, T. J. D., Hallberg, C., Birch, A. M., Lees, D., & Jones, H. B. (2013) · Toxicologic Pathology · doi:10.1177/0192623313477753 · Cited by 14
“2] oct-1-ylgacetic acid) was synthesized by AstraZeneca R&D, Alderley Park, United Kingdom, and has selective DGAT1 inhibitory activity (Birch et al. 2009).”
MethodInfluentialSelf-citationZhang, X.-D., Yan, J., Yan, G., Sun, X.-Y., Ji, J., Li, Y., Hu, Y., & Wang, H. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.104 · Cited by 17
Tabor, G. T., Litvinchuk, A., Chen, Y., Allison, A., Sun, E. W., van Lengerich, B., Davis, S. S., West, E., Schlachetzki, J. C. M., Zeng, C., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116841 · Cited by 14
“If the brain myeloid lipid accumulations observed in postmortem AD or primary tauopathy brains are found to predominantly localize to lysosomes and not LDs as we observed in our PS19 mice, this would suggest that ameliorating endolysosomal dysfunction may be a more relevant and rational therapeutic goal than modulatin…”
InfluentialLee, K., Kim, M., Lee, B., Goo, J., Kim, J., Naik, R., Seo, J. H., Kim, M. O., Byun, Y., Song, G., et al. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob27114a · Cited by 13
Обыденнов, Д. Л., Goncharov, A. O., & Sosnovskikh, V. Y. (2016) · Russian Chemical Bulletin · doi:10.1007/s11172-016-1574-x · Cited by 13
Enterocyte Fatty Acid Handling Proteins and Chylomicron Formation
Cifarelli, V., & Abumrad, N. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00048-7 · Cited by 16
Maciejewski, B. S., Manion, T. B., & Steppan, C. M. (2017) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v8.i4.161 · Cited by 9
Waring, M. J., Birch, A. M., Birtles, S., Buckett, L. K., Butlin, R. J., Campbell, L., Gutierrez, P. M., Kemmitt, P. D., Leach, A. G., MacFaul, P. A., et al. (2012) · MedChemComm · doi:10.1039/c2md20190a · Cited by 9
Self-citationPlowright, A. T., Barton, P., Bennett, S. N. L., Birch, A. M., Birtles, S., Buckett, L. K., Butlin, R. J., Davies, R. D. M., Ertan, A., Gutierrez, P. M., et al. (2012) · MedChemComm · doi:10.1039/c2md20187a · Cited by 8
Self-citationYu, T., Wu, C., Shih, N., Li, Q., Chan, C.-C., Pan, H., Yao, D., Pan, Y., Liang, W., Shen, L., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.04.051 · Cited by 8
Goldberg, F. W., Birch, A. M., Leach, A. G., Groombridge, S. D., Snelson, W. L., Gutierrez, P. M., Hammond, C. D., Birtles, S., & Buckett, L. K. (2012) · MedChemComm · doi:10.1039/c2md20231j · Cited by 7
Self-citationGutierrez, P. M., Yates, J. W. T., Nilsson, C. A. M., & Birtles, S. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.465 · Cited by 9
“Full description of the OLTT in the rat has been published previously.(17) In brief, 53 male Han‐Wistar rats (∼230 g), previously maintained on a chow diet, were fasted for 14 hours.”
MethodSelf-citationThe Checkpoints of Intestinal Fat Absorption in Obesity
Engin, A. B., & Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_3 · Cited by 9
Yan, J., Wang, G., Dang, X.-Y., Guo, B., Chen, W., Wang, T., Zeng, L., Wang, H., & Hu, Y. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.07.007 · Cited by 6
“phenyl)nicotinoyl)pyrrolidine-2-carboxylic acid (18)”
BackgroundEnzymatic Targets in the Triglyceride Synthesis Pathway
Koltun, D. O., & Zablocki, J. A. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45007-1 · Cited by 6
High-throughput approaches to investigate neutral lipid biosynthesis
Weselake, R. J. (2010) · International Journal of High Throughput Screening · doi:10.2147/ijhts.s9763 · Cited by 4
“A compound of the pyrimidino-oxazine class of DGAT-1 inhibitors also shows effective body weight reduction in mice.(29) These and other studies(30) suggest that small molecule inhibitors of DGAT have the potential to be used in the treatment of obesity and metabolic syndrome, underscoring the significance of an effici…”
Triacylglycerol synthesis and energy metabolism: a gut reaction?
Nelson, D., & Yen, C. E. (2009) · Clinical Lipidology · doi:10.2217/clp.09.67 · Cited by 4
A Collection of Novel Antitumor Agents That Regulate Lipid Metabolism in the Tumor Microenvironment
Zhang, J., Xu, S., Yue, L., Lei, H., & Zhai, X. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02809 · Cited by 3
Deskeuvre, M., Lan, J., Messens, J., Riant, O., Féron, O., & Frédérick, R. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124132 · Cited by 3
Nakao, S., Saikai, M., Nishimoto, Y., & Yasuda, M. (2020) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202001342 · Cited by 3
Omar, Y. M., Santucci, G., & Afarinkia, K. (2022) · Molecules · doi:10.3390/molecules27175666 · Cited by 2
One-Pot Assembly of 2-Pyrones through Copper-Catalyzed Cyclization of Propargylamines with Malonates
Li, J., Liu, S., Huang, L., Huang, J., & Feng, H. (2025) · Precision Chemistry · doi:10.1021/prechem.5c00091 · Cited by 1
DISCOVERY AND DEVELOPMENT OF ISOZYME‐SELECTIVE INHIBITORS INVOLVED IN LIPID METABOLISM
Ohshiro, T., & Tomoda, H. (2013) · Wiley eBooks · doi:10.1002/9781118739907.ch2
Hypertriglyceridemia: the future of genetics to guide individualized therapeutic strategies
Moens, S. J. B., Hassing, C., Nieuwdorp, M., Stroes, E. S. G., & Dallinga‐Thie, G. M. (2013) · Clinical Lipidology · doi:10.2217/clp.13.23
Bicyclic 6-6 Systems: Other Four Heteroatoms 2:2
Moreau, P., & Anizon, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14956-x
Koul, S., Kurhade, S. E., Bhosale, S., Naik, K., Salunkhe, V. T., Ravula, S., Punde, P., Velayutham, R., Tiwari, A., Ahl, D., et al. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128632
Zhang, W., & Zhai, R. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.740510745.793587739
Exceptional reactivity of the bridgehead amine on bicyclo[1.1.1]pentane
Lu, Y., & Chen, C. (2023) · ARKIVOC · doi:10.24820/ark.5550190.p012.003
Singh, A., Mansi, Khanna, P., Gupta, D., Singh, S. K., & Khanna, L. (2025) · ChemistrySelect · doi:10.1002/slct.202502210
BindingDB (2015) · UC San Diego · doi:10.7270/q2ks6t3c
Metadata
- Authors
- Birch, A. M., Birtles, S., Buckett, L. K., Kemmitt, P. D., Smith, G. J., Smith, T. J. D., Turnbull, A. V., & Wang, S. J. Y.
- Affiliations
- AstraZeneca (United Kingdom) (GB)
- Corresponding author
- Birch, Alan M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-03-03
- Volume
- 52
- Issue
- 6
- Pages
- 1558-1568
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1993583808
- Cited by
- 77
- References
- 18
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 3 · 2014: 9 · 2013: 10 · 2012: 10
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- diacylglycerol acyltransferase 1, obesity, metabolic syndrome, diet-induced obesity, oral bioavailability, pharmacokinetics, adipose tissue, intestinal tissue, weight loss
- MeSH terms
- Administration, Oral, Animals, Body Weight, Enzyme Inhibitors, Female, Humans, Male, Mice, Inbred C57BL, Magnetic Resonance Spectroscopy, Obesity, Oxazines, Pyrimidines, Rats, Wistar, Spectrometry, Mass, Electrospray Ionization, Diacylglycerol O-Acyltransferase, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.